Gilead Sciences Inc (GILD) Common Stock USD0.001

Sell:$128.20Buy:$128.26Price decreased$1.02 (0.79%)

NASDAQ:Price increased0.15%
Market closed |
Prices delayed by at least 15 minutes
Sell:$128.20
Buy:$128.26
Change:Price decreased$1.02 (0.79%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:$128.20
Buy:$128.26
Change:Price decreased$1.02 (0.79%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$128.49
Previous close$129.26
Market cap$158.57bn
P/E ratio15.84
Volume161,875
Dividend yield2.54%
EMS-

Company information

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue1.24bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share$0.82
  • Ex-dividend date13 March 2026
  • Payment date30 March 2026

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.